Does ATORVASTATIN Cause Hypertransaminasaemia? 207 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 207 reports of Hypertransaminasaemia have been filed in association with ATORVASTATIN (Atorvastatin calcium). This represents 0.3% of all adverse event reports for ATORVASTATIN.
207
Reports of Hypertransaminasaemia with ATORVASTATIN
0.3%
of all ATORVASTATIN reports
19
Deaths
91
Hospitalizations
How Dangerous Is Hypertransaminasaemia From ATORVASTATIN?
Of the 207 reports, 19 (9.2%) resulted in death, 91 (44.0%) required hospitalization, and 36 (17.4%) were considered life-threatening.
Is Hypertransaminasaemia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ATORVASTATIN. However, 207 reports have been filed with the FAERS database.
What Other Side Effects Does ATORVASTATIN Cause?
Type 2 diabetes mellitus (7,556)
Myalgia (7,155)
Drug hypersensitivity (3,929)
Drug ineffective (3,865)
Fatigue (3,439)
Arthralgia (3,338)
Rhabdomyolysis (3,286)
Dyspnoea (3,137)
Nausea (2,888)
Asthenia (2,791)
What Other Drugs Cause Hypertransaminasaemia?
METHOTREXATE (436)
ACETAMINOPHEN (326)
PACLITAXEL (318)
CARBOPLATIN (304)
PEMBROLIZUMAB (231)
CYCLOPHOSPHAMIDE (202)
PREDNISONE (198)
GEMCITABINE (196)
DEXAMETHASONE (169)
RITUXIMAB (168)
Which ATORVASTATIN Alternatives Have Lower Hypertransaminasaemia Risk?
ATORVASTATIN vs ATORVASTATIN\EZETIMIBE
ATORVASTATIN vs ATOSIBAN
ATORVASTATIN vs ATOVAQUONE
ATORVASTATIN vs ATOVAQUONE\PROGUANIL
ATORVASTATIN vs ATRACURIUM